Day 2 - Lung Cancer Update - 10 Oct 2020
VIRTUAL UPDATE 4th Annual International PRECISION ONCOLOGY & IBC CONFERENCE JAIPUR
Part 1 - Welcome and Introduction - Dr. Sandeep Jasuja, Jaipur
Part 2 - Immunotherapy current scenario and future trends in Lung Cancer - Dr. Balazs Halmos
Part 3 - IM power 133-Tecentriq plus chemo in 1L ES-SCLC - Dr. Kumar Prabhash, Mumbai
Part 4 - Optimal management of EGFR m NSCLC patients - Dr. Shyam Agarwal, Delhi
Part 5 - Screening diagnosis & Molecular Marker in Lung Cancer - Dr. Lim, Kiat Hon Tony, Singapore
Part 6 - Immune related adverse events with PDL1 and ctla4 inhibitors - Dr. Raya Leibowitz, Israel
Part 7 - Panel Discussion: Management of early stage Lung Cancer - Virtual Tumor Board - Dr. Raman
Part 8 - Case based Panel Discussion - Dr. Palanki Satya Dattatreya, Hyderabad
Part 9-Virtual Tumor Board: Immune Checkpoint Inhibitors in the management of Lung Cancer- Dr. Ullas
Part 10 - Advances in the Management of Triple –Negative Breast Cancer - Dr. Lee Soo Chin, Singapore
Part 11 - Panel Discussion: Virtual Tumor Board : TNBC - New Horizons? - Dr. Shyam Aggarwal, Delhi
Part 12 - Take home message & Vote of Thanks - Dr. Ankush Rathi, Jaipur